Author

Kazuko Fujihara

Institutions: Mayo Clinic, University of California, San Francisco, Hospices Civils de Lyon, Hôpital Pierre Wertheimer, National Cancer Center, Mayo Clinic in Arizona, University of Colorado Cancer Center, National Cancer Center Hospital, University of Colorado Anschutz

Observed institutions: Mayo Clinic, University of California, San Francisco, Hospices Civils de Lyon, Hôpital Pierre Wertheimer, National Cancer Center, Mayo Clinic in Arizona, University of Colorado Cancer Center, National Cancer Center Hospital, University of Colorado Anschutz

OpenAlex ID: A5110752153

Disability Outcomes in the N-MOmentum Trial of Inebilizumab in Neuromyelitis Optica Spectrum Disorder

2021 · Romain Marignier, Jeffrey L. Bennett, et al. · Neurology Neuroimmunology & Neuroinflammation · 44

Works count: 1

Citation count: 44

H-index: 1

I10-index: 1